Sinusoidal Obstructive Syndrome Prophylaxis With Recombinant Human Soluble Thrombomodulin Is Feasible in Gemtuzumab Ozogamicin-Treated Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2017.65
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of Low-Dose Zoster Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2019English

Drug-Induced Thrombotic Thrombocytopenic Purpura Successfully Treated With Recombinant Human Soluble Thrombomodulin

Internal Medicine
Internal MedicineMedicine
2013English

Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Patients With Prior Gemtuzumab Ozogamicin: Literature Analysis of Survival After Defibrotide Treatment

Blood Cancer Journal
OncologyHematology
2020English

Impact of T-Cell Depletion on Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2018English

Systematic Anti-Mold Prophylaxis Results in Very Low Incidence of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Hepatic Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation

Oncology Nursing Forum
Oncology
2008English

Risk Factors for Acute Kidney Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Chinese Journal of Cancer
2010English

Torque Teno Virus in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Bone Marrow Transplantation
TransplantationHematology
2015English

Determination of Th1/Th2/Th17 Cytokines in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy